Tech Blog

Lungpacer Medical, Inc.

Last verified 2026-05-07. JSON

The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.

Total raised$12.0Mattributed
Latest roundFunding round, $12.0M, 2026-04-23attributed
Foundedunknown
HeadquartersEXTON, PA
Industryother health care
Stageunknown
Websitelungpacer.com

Lungpacer makes the AeroPace neurostimulation system that paces the phrenic nerve to wean critically-ill patients off mechanical ventilation. It serves ICU teams treating adult patients ventilated for 96+ hours who have not weaned successfully. Trial data show 43% faster weaning, 3.2 fewer ventilator days, and 47% lower reintubation versus standard care.

Funding rounds

DateRoundAmountLead
2026-04-23Funding round$12.0Mundisclosed

Detected tech stack

Cloudflare, WordPress, Yoast SEO 27.5, Yoast SEO Premium 27.5, Google Tag Manager, Swiper, Cloudflare Bot Management, WP Engine, PHP, MySQL

Provenance

FactStatusBasis
Funding round, $12.0Mattributedsec-edgar named as publisher. No document URL on file.
Total raised $12.0Mattributedsec-edgar named as publisher. No document URL on file.
Company existenceself-reportedlungpacer.com, read 2026-05-07
Descriptionself-reportedlungpacer.com, read 2026-05-07

Nothing on this page is sourced yet. A sourced fact links to a document that states it.

Change history

Date
2026-09-25Latest round: seed, $12.0M, 2026-04-23 → Funding round, $12.0M, 2026-04-23, sec-edgar, No document URL on file

Records begin 2026-09-24. All changes